Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of Equecabtagene Autoleucel Injection in relapsed/refractory multiple myeloma
CTR20240952Phase 4Active
- Sponsor
- Reindeer Biotech
- Start
- Jul 2024
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, Gene Therapies
- Countries
- 1
01
Overview
A Phase 4 trial of equecabtagene autoleucel in multiple myeloma (MM), sponsored by Reindeer Biotech. Started Jul 2024; status: active.
02
Drugs
equecabtagene autoleucel
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20240952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20240952.